Associate Professor of Surgery, University Wisc
General Surgery
Dr. Herbert Chen, MD
|
|
Give Review
Herbert Chen works in the field of General Surgery. He went to Duke University School of Medicine. Duke University School of Medicine is a top medical college. Duke University School of Medicine has a rank of 8 in research and a 29 in primary care He over the years received 3 awards: "CMS Meaningful Use Stage 1 Certification", "Elected Member" and "Fellow (FACS)". Dr. Herbert Chen is a published doctor and has 100 publications published. The lastest was: 'Thailandepsin A-loaded and octreotide-functionalized unimolecular micelles for targeted neuroendocrine cancer therapy.'
Publications
- When patients call their surgeon's office: an opportunity to improve the quality of surgical care and prevent readmissions.
- Compromised Outcome of Papillary Thyroid Cancer at Low-Volume Treatment Centers: Practice Makes Perfect?
- Notch1 Signaling Regulates the Aggressiveness of Differentiated Thyroid Cancer and Inhibits SERPINE1 Expression.
- Substernal goiter: when is a sternotomy required?
- Kidney Disease Improving Global Outcomes guidelines and parathyroidectomy for renal hyperparathyroidism.
- Prospective Intervention of a Novel Levothyroxine Dosing Protocol Based on Body Mass Index after Thyroidectomy.
- The relationship between radiographic parameters and clinical outcome of distal radius fractures in elderly patients.
- Surgery: Papillary thyroid Cancer-how aggressive should surgery be?
- Is intraoperative parathyroid hormone testing in patients with renal insufficiency undergoing parathyroidectomy for primary Hyperparathyroidism accurate?
- Radioguided parathyroidectomy for tertiary Hyperparathyroidism.
- Lymph node metastases do not impact survival in follicular variant papillary thyroid Cancer.
- The effect of cinacalcet on intraoperative findings in tertiary Hyperparathyroidism patients undergoing parathyroidectomy.
- Is central lymph node dissection necessary for parathyroid Carcinoma?
- Evaluation and Management of the Pediatric Thyroid Nodule.
- Tumor suppressor role of Notch3 in Medullary Thyroid Carcinoma revealed by genetic and pharmacological induction.
- Thiocoraline activates the Notch pathway in carcinoids and reduces Tumor progression in vivo.
- Justified Follow-Up: A Final Intraoperative Parathyroid Hormone (ioPTH) Over 40 pg/mL is Associated with an Increased Risk of Persistence and Recurrence in Primary Hyp...
- Preventing Postoperative Hypocalcemia in Patients with Graves Disease: A Prospective Study.
- CaPTHUS Scoring Model in Primary Hyperparathyroidism: Can It Eliminate the Need for ioPTH Testing?
- All Thyroid Ultrasound Evaluations are Not Equal: Sonographers Specialized in Thyroid Cancer Correctly Label Clinical N0 Disease in Well Differentiated Thyroid Cancer.
- Outcomes After Subtotal Parathyroidectomy for Primary Hyperparathyroidism due to Hyperplasia: Significance of Whole vs. Partial Gland Remnant.
- Clinical and Socioeconomic Factors Influence Treatment Decisions in Graves' Disease.
- Chasing Calcitonin: Reoperations for Medullary Thyroid Carcinoma.
- Identifying predictors of a difficult Thyroidectomy.
- Failure of Radioactive Iodine in the Treatment of HyperThyroidism.
- The Roles of the Epithelial-Mesenchymal Transition Marker PRRX1 and MicroRNA 146b-5p in Papillary Thyroid Carcinoma Progression.
- Surgeon and Staff Radiation Exposure During Radioguided Parathyroidectomy at a High-Volume Institution.
- Parathyroid conditions in childhood.
- Primary Hyperparathyroidism across the ages: presentation and outcomes.
- Elevated Parathyroid hormone after Parathyroidectomy delays symptom improvement.
- Distinguishing classical papillary thyroid microCancers from follicular-variant microCancers.
- Role of cervical ultrasound in detecting thyroid pathology in primary Hyperparathyroidism.
- Surgical site infection after Thyroidectomy: a rare but significant complication.
- Novel Thyroidectomy Difficulty Scale Correlates with Operative Times.
- Markedly elevated thyroglobulin levels in the preoperative Thyroidectomy patient correlates with metastatic burden.
- Recurrent and persistence primary Hyperparathyroidism occurs more frequently in patients with double adenomas.
- The novel histone deacetylase inhibitor thailandepsin A inhibits anaplastic thyroid Cancer growth.
- Propensity for social interaction predicts nicotine-reinforced behaviors in outbred rats.
- Specific glycogen synthase kinase-3 inhibition reduces Neuroendocrine markers and suppresses neuroblastoma cell growth.
- Thyroidectomy as Primary Treatment Optimizes Body Mass Index in Patients with HyperThyroidism.
- Hesperetin Activates the Notch1 Signaling Cascade, Causes Apoptosis, and Induces Cellular Differentiation in Anaplastic Thyroid Cancer.
- Postoperative surveillance of small appendiceal carcinoid Tumors.
- Radioactive Iodine Remnant Uptake After Completion Thyroidectomy: Not Such a Complete Cancer Operation.
- A Survey of Preferences Regarding Surgical Approach to Thyroid Surgery.
- The role of epithelial mesenchymal transition markers in thyroid Carcinoma progression.
- Timing of symptom improvement after parathyroidectomy for primary Hyperparathyroidism.
- Predictors of Recurrence in Primary Hyperparathyroidism: An Analysis of 1386 Cases.
- An intact Parathyroid hormone-based protocol for the prevention and treatment of symptomatic hypocalcemia after thyroidectomy.
- Improvement of Sleep Disturbance and Insomnia Following Parathyroidectomy for Primary Hyperparathyroidism.
- A multi-institutional international study of risk factors for hematoma after Thyroidectomy.
- Octreotide-functionalized and resveratrol-loaded unimolecular micelles for targeted neuroendocrine Cancer therapy.
- Current Understanding and Management of Medullary Thyroid Cancer.
- MultiGland Disease and Slower Decline in Intraoperative PTH Characterize Mild Primary Hyperparathyroidism.
- Minimal Benefit to Subsequent Intraoperative Parathyroid Hormone Testing After All Four Glands Have Been Identified.
- Presentation, Management, and Outcomes of Hyperparathyroidism in Octogenarians and Nonagenarians.
- MK-2206 Causes Growth Suppression and Reduces Neuroendocrine Tumor Marker Production in Medullary Thyroid Cancer Through Akt Inhibition.
- Drug ligand-induced activation of translocator protein (TSPO) stimulates steroid production by aged brown Norway rat Leydig cells.
- Leflunomide suppresses growth in human medullary thyroid Cancer cells.
- Radioguided Parathyroidectomy effective in pediatric patients.
- Clinicopathologic characteristics of colonic carcinoid Tumors.
- Significance of rebounding Parathyroid hormone levels during Parathyroidectomy.
- Increased efficiency of endocrine procedures performed in an ambulatory operating room.
- A short-stay unit for Thyroidectomy patients increases discharge efficiency.
- Unilateral Thyroidectomy for the treatment of benign multinodular goiter.
- Consensus Guidelines for the Management and Treatment of Neuroendocrine Tumors.
- Radioactive iodine scanning is not beneficial but its use persists for euThyroid patients.
- The incidence of thyroid Cancer by f?ine needle aspiration varies by age and gender.
- Resveratrol Induces Differentiation Markers Expression in Anaplastic Thyroid Carcinoma via Activation of Notch1 Signaling and Suppresses Cell Growth.
- Toxic nodular goiter and Cancer: a compelling case for thyroidectomy.
- Synchronous and Antecedent Nonthyroidal Malignancies in Patients with Papillary Thyroid Carcinoma.
- Doing Away with the Rule of 10 %
- Parathyroid Cryopreservation after Parathyroidectomy: A Worthwhile Practice?
- Nondiagnostic fine-needle aspirations of the Thyroid: is the risk of malignancy higher?
- Follicular Variant of Papillary Thyroid Carcinoma is a Unique Clinical Entity: A Population-Based Study of 10,740 Cases.
- Early-phase technetium-99m sestamibi scintigraphy can improve preoperative localization in primary Hyperparathyroidism.
- Using body mass index to predict optimal Thyroid dosing after Thyroidectomy.
- REMNANT UPTAKE AS A POSTOPERATIVE ONCOLOGIC QUALITY INDICATOR.
- Chrysin activates Notch1 signaling and suppresses tumor growth of anaplastic thyroid Carcinoma in vitro and in vivo.
- Utility of (111)Indium-pentetreotide Scintigraphy in Patients with Neuroendocrine Tumors.
- Lymph Node Ratio Predicts Recurrence in Papillary Thyroid Cancer.
- Incidence and localization of ectopic Parathyroid adenomas in previously unexplored patients.
- Expression of epithelial-mesenchymal transition regulators SNAI2 and TWIST1 in thyroid Carcinomas.
- Neuroendocrine phenotype alteration and growth suppression through apoptosis by MK-2206, an allosteric inhibitor of AKT, in carcinoid cell lines in vitro.
- Impact of Lymph Node Ratio on Survival in Papillary Thyroid Cancer.
- Intrathyroidal parathyroid Glands: Small, but mighty (a Napoleon phenomenon).
- Is previous same quadrant surgery a contraindication to laparoscopic Adrenalectomy?
- Symptoms of gastroesophageal reflux Disease improve after parathyroidectomy.
- Same-day Thyroidectomy program: Eligibility and safety evaluation.
- Is Thyroidectomy in patients with Hashimoto Thyroiditis more risky?
- Hereditary Medullary Thyroid Cancer: Age-Appropriate Thyroidectomy Improves Disease-Free Survival.
- Co-delivery of doxorubicin and siRNA using octreotide-conjugated gold nanorods for targeted neuroendocrine Cancer therapy.
- Is minimally invasive Parathyroidectomy associated with greater recurrence compared to bilateral exploration? Analysis of more than 1,000 cases.
- Laparoscopic resection is safe and feasible for large (≥ 6cm) pheochromocytomas without suspicion of malignancy.
- Persistent hypertension after Adrenalectomy for an aldosterone-producing adenoma: weight as a critical prognostic factor for aldosterone's lasting effect on the cardia...
- Current treatment of papillary thyroid microCarcinoma.
- Sestamibi Imaging for Primary Hyperparathyroidism: The Impact of Surgeon Interpretation and Radiologist Volume.
- Routine Chest X-Ray Prior to Thyroid Surgery: Is It Always Necessary?
- Changes in Swallowing-Related Quality of Life after Parathyroidectomy for Hyperparathyroidism: A Prospective Cohort Study.
- Thailandepsin A-loaded and octreotide-functionalized unimolecular micelles for targeted neuroendocrine Cancer therapy.
Schools
Duke University
Johns Hopkins Hospital
Procedures Preformed
- Adrenalectomy
- Appendectomy, Laparoscopic
- Intestinal Transplant (incl. Enterectomy)
- Lymph Node Biopsy or Excision
- View All
Conditions Treated
- Abdominal Pain
- Adrenal Gland Cancer
- Appendicitis
- Atelectasis
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Elected Member
- Fellow (FACS)
Education
-
Johns Hopkins University -
Duke University School of Medicine
Hospital
-
University of Wisconsin Hospital and Clinics -
University of Alabama Hospital
Drug Facts
| NPI NUMBER | 1366407033 | |
| NPPES Provider LastName | CHEN | |
| NPPES Provider FirstName | HERBERT | |
| NPPES Provider ZIPCode | 53792 | |
| NPPES Provider State | WI | |
| Specialty Description | General Surgery | |
| Total Claim Count | 71.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1366407033 |
| Last Name Of The Provider | CHEN |
| First Name Of The Provider | HERBERT |
| View All |
Similar Doctors
|
|
Dr. Kenneth E. Levin, MD |
|
|
Dr. Peter M. Thurlow, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Folkert O. Belzer, MD |
|
|
Dr. Philip Y. Wai, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael D. Rizzari, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ryan K. Schmocker, MD
This Doctor is OpenDoctor Recommended.
|